<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31711">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01818518</url>
  </required_header>
  <id_info>
    <org_study_id>OBX0022</org_study_id>
    <nct_id>NCT01818518</nct_id>
  </id_info>
  <brief_title>Neonatal Outcome by Reason for Delivery</brief_title>
  <official_title>Neonatal Outcome by Reason for Delivery - A Prospective, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Obstetrix Medical Group</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Obstetrix Medical Group</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the rate of Composite Neonatal Morbidity for very preterm babies delivered
      secondary to preterm labor (PTL) vs. prelabor rupture of membranes (PROM).  Composite
      neonatal morbidity is defined as ≥ 1 of the following: Respiratory Distress Syndrome (RDS)
      (oxygen requirement, clinical diagnosis, and consistent chest radiograph), bronchopulmonary
      dysplasia (BPD) (requirement for oxygen support at 28 days of life), severe intraventricular
      hemorrhage (IVH) (grades III or IV), periventricular leukomalacia (PVL), blood
      culture-proven sepsis, necrotizing enterocolitis (NEC), or perinatal death (stillbirth or
      death before neonatal hospital discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, observational study that will use information from the medical
      records of mothers and their newborns.  This study seeks to determine the rate of Composite
      Neonatal Morbidity for very preterm babies delivered secondary to preterm labor (PTL) vs.
      prelabor rupture of membranes (PROM).  Composite neonatal morbidity is defined as ≥ 1 of the
      following: Respiratory Distress Syndrome (RDS) (oxygen requirement, clinical diagnosis, and
      consistent chest radiograph), bronchopulmonary dysplasia (BPD) (requirement for oxygen
      support at 28 days of life), severe intraventricular hemorrhage (IVH) (grades III or IV),
      periventricular leukomalacia (PVL), blood culture-proven sepsis, necrotizing enterocolitis
      (NEC), or perinatal death (stillbirth or death before neonatal hospital discharge.

      Secondary Objectives: 1) Difference in mortality between the PTL and PROM groups, composite
      morbidity differences for other reasons for premature delivery, and individual morbidities
      including IVH, PVL, RDS, sepsis, seizures, BPD and NEC

      Study Population: All babies from singleton pregnancies delivering in each of the involved
      hospitals who deliver at less than 32 weeks of gestation who are stillborn, who die in the
      delivery room and who are cared for in the Neonatal Intensive Care Unit (NICU) will be
      included.

      Planned Sample Size: We plan a two year study and estimate based on historical data for the
      institutions to be included in the study, which should yield approximately 6000 babies less
      than (&lt;) 32w0d  gestation.  For a 10% difference in composite morbidity (assuming 90% power
      and two-sided alpha=0.05) assuming a rate of 60% at least 661 patients are needed in each of
      the 3 groups (PTL, PROM, and other).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Composite Perinatal Morbidity</measure>
    <time_frame>From birth until neonatal hospital discharge (from birth + or minus 6 months)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome is Composite Perinatal Morbidity.  Composite morbidity is defined as ≥ 1 of the following: RDS (oxygen requirement, clinical diagnosis, and consistent chest radiograph), BPD (requirement for oxygen support at 28 days of life), severe IVH (grades III or IV), PVL, blood culture-proven sepsis present within 72 hours of birth, NEC, or perinatal death (stillbirth or neonatal death prior to hospital discharge).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality and morbidity differences between groups</measure>
    <time_frame>Birth until neonatal hospital discharge (from birth + or minus 6 months of age)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Secondary outcomes with be mortality difference between the preterm labor and prelabor rupture of membranes groups, composite morbidity  and mortality differences between the other reasons for premature delivery, and individual morbidities including IVH, PVL, RDS, sepsis, seizures, BPD and NEC</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Preterm Delivery</condition>
  <arm_group>
    <arm_group_label>Preterm Labor</arm_group_label>
    <description>Group who goes into labor prior to 32 weeks of gestation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prelabor rupture of membranes</arm_group_label>
    <description>Group who have prelabor rupture of membranes are those who break their bag of water prior to 32 weeks gestation in the absence of labor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Premature birth before 32 weeks gestation</arm_group_label>
    <description>Premature birth before 32 weeks gestation not including PTL or PROM</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All babies from singleton pregnancies delivering in each of the involved hospitals who
        delivered at less than 32 weeks of gestation and who are stillborn, who die in the
        delivery room and who are cared for in the Neonatal Intensive Care Unit (NICU) will be
        included.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Delivery at participating hospitals at less than 32weeks of gestation based on best
             obstetrical dating

          -  Singleton pregnancy

          -  Delivery where the baby is:

               1. Stillborn OR

               2. Born alive and:

          -  expires before it leaves the delivery room OR

          -  is cared for in the Neonatal Intensive Care Unit or an Intermediate Care Nursery

        Exclusion Criteria:

          -  Patient less than 18 years of age

          -  Pregnancies that had previously been multiple gestations but where one or more
             fetuses had died after 12weeks of gestation

          -  Deliveries where the baby is born alive, does not expire in the delivery room but the
             baby does not get admitted to the NICU.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Garite, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Obstetrix Medical Group</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly Maurel, MSN</last_name>
    <phone>714-593-9171</phone>
    <email>kimberly_maurel@pediatrix.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana Abril, MS</last_name>
    <phone>480-659-8644</phone>
    <email>diana_abril@pediatrix.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Banner Desert Medical Center</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana B Braescu, RN, MSN</last_name>
      <phone>602-257-8118</phone>
      <phone_ext>135</phone_ext>
      <email>Ana_braescu@PEDIATRIX.COM</email>
    </contact>
    <investigator>
      <last_name>Monique G Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Banner Good Samaritan Medical Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana V Bodea Braescu, RN, BSN</last_name>
      <phone>602-257-8118</phone>
      <phone_ext>135 or 137</phone_ext>
      <email>ana_braescu@PEDIATRIX.COM</email>
    </contact>
    <contact_backup>
      <last_name>Michelle M Gamez, RN</last_name>
      <phone>602-722-9564</phone>
      <email>michelle_gamez@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Monique G Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scottsdale Healthcare-Shea Medical Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moniquie Lin, MD</last_name>
      <phone>602-257-8118</phone>
      <email>monique_lin@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Ana Braescu, MSN</last_name>
      <phone>602-614-0488</phone>
      <email>ana_braescu@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Monique Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saddleback Memorial Medical Center</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Bush, MD</last_name>
      <phone>949-452-7199</phone>
      <email>melissa_bush@pediatrix.com</email>
    </contact>
    <investigator>
      <last_name>Melissa Bush, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Good Samaritan Hospital</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Combs, MD</last_name>
      <phone>408-371-7111</phone>
      <email>andrew_combs@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Kimberly Mallory, RN</last_name>
      <phone>408-371-7111</phone>
      <email>kimberly_mallory@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Combs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presbyterian/St Luke's Hospital</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Porreco, MD</last_name>
      <phone>303-860-9990</phone>
      <email>richard_porreco@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Julie Rael, RN</last_name>
      <phone>303-570-8138</phone>
      <email>julie_rael@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard Porreco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital, Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Lu</last_name>
      <phone>816-932-6903</phone>
      <email>glu@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>George Lu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital of St. Louis</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Morris, MD</last_name>
      <phone>314-991-5000</phone>
      <email>bmorrismfm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bruce Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harris Methodist Hospital - Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>April Bleich</last_name>
      <phone>817-878-5298</phone>
      <email>april_bleich@pediatrix.com</email>
    </contact>
    <investigator>
      <last_name>April Bleich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122-4307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dale Reisner, MD</last_name>
      <phone>206-386-2101</phone>
      <email>dale_reisner@pediatrix.com</email>
    </contact>
    <contact_backup>
      <last_name>Tina Lopez, RN</last_name>
      <phone>206-215-3541</phone>
      <email>tina_lopez@pediatrix.com</email>
    </contact_backup>
    <investigator>
      <last_name>Dale Reisner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 28, 2014</lastchanged_date>
  <firstreceived_date>March 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Preterm delivery</keyword>
  <keyword>Premature delivery</keyword>
  <keyword>Premature birth</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Premature Birth</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
